Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Quick Stats
Jan 30, 202662.9
AI Score
BUY2.08
Volume Ratio
Mar 26, 2026
Next Earnings
19
+ve Days (30d)
11
-ve Days (30d)
CATX Stock Summary
Last updated Jan 30, 2026
CATX is currently trading at $3.79, positioned above its 200-day moving average of $3.08, indicating a long-term uptrend. The stock has a 52-week range of $1.6 to $6.16.
Technical Analysis: The 50-day moving average stands at $2.6, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.627, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.099, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CATX at 62.9/100 with a BUY recommendation.
CATX (Perspective Therapeutics, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 65.627 |
| CMF (20) | -0.099 |
| ROC (10) | 52.823 |
| ADX (14) | 22.917 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.191 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -60.614 |
| MFI (14) | 87.038 |
CATX Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CATX Price vs Max Options Open Interest
CATX Max Change In Options Open Interest
CATX Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CATX Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CATX Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CATX Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Perspective Therapeutics, Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CATX Moving Averages Analysis
Perspective Therapeutics, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Perspective Therapeutics, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
CATX (Perspective Therapeutics, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 2.86 |
| 20 | 2.77 |
| 30 | 2.77 |
| 50 | 2.6 |
| 100 | 2.91 |
| 200 | 3.08 |
CATX Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 190.3 million |
| Earnings/Share ($) | -1.51 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.2127 |
| EPS Estimate Next Year ($) | -1.3558 |
| WallStreet Target Price ($) | 12.3077 |
| Most Recent Quarter |